NPC1L1 Antibodies

Santa Cruz Biotechnology provides a broad selection of NPC1L1 monoclonal antibodies for various research applications. NPC1L1 Antibodies are optimized for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Niemann-Pick C1-like 1 (NPC1L1) is essential for cholesterol absorption and lipid metabolism, playing a significant role in maintaining cellular lipid homeostasis. NPC1L1 function is particularly important for cardiovascular health and metabolic disorders, making it a key target for therapeutic interventions. Understanding NPC1L1 can provide insights into various diseases, including atherosclerosis and diabetes. Research focused on NPC1L1 continues to reveal new aspects of lipid metabolism and transport mechanisms. Investigating NPC1L1 expression patterns helps scientists better understand its role in different tissues and physiological conditions. The development of targeted therapies for metabolic disorders benefits from detailed molecular studies of NPC1L1. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of lipid metabolism and its impact on human health.